Our study provides a strong evidence of profound effects of irreversible pan-EGFR inhibitors (TKIs) in down regulating MUC4 mucin through its effect on the EGFR family proteins resulting in decreased pancreatic cancer cell proliferation, survival and migration. The gene discussed is MUC5AC; the disease is pancreatic neoplasm.